Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Helen Reid. Reach her on Messenger to share your thoughts on market moves: helen.reid.thomsonreuters.com@reuters.net
THE WORST MONTH SINCE 2011? (1113 GMT)
Just a short while ago, European shares were set for their worst month since August 2015, now it's looking more like August 2011. We're currently down 8.7 percent on the month, Aug 2015 saw an 8.4 percent fall, and Aug 2011 was a 10.5 percent drawdown.
In the grander scheme of things there's only been 14 months as bad as October 2018 (so far) in the last 30 years - as you can see below in the monthly chart.
Which means we're in the top 4 percent as far as bad months go!
(Julien Ponthus)
*****
CANNABIS GETS YOU HIGH, EVEN IN A SELL-OFF (1017 GMT)
Roughly 90 percent of the STOXX 600 is in negative territory but that hasn't spoiled Danish cannabis firm StenoCare's STENO.TE stock market debut.
Its shares have more than tripled in value this morning, worth remembering next time a company decides to cancel an IPO and lamely blames it on "adverse market conditions".
It's been said for a while now that cannabis could be the new blockchain in terms of stoking a market frenzy and it seems the craze is spreading.
Pot stocks are hot and not only in Canada, which just became the first Group of Seven nation to legalize recreational cannabis.
We've already used this illustration (taken from the twitter account of GAM fund manager Paul McNamaraon) but hey, a second time can't hurt:
Pot is hot! Shares in Danish cannabis firm StenoCare surge on debut MARKETS-Is cannabis the new blockchain? nL8N1WS4AE]
(Julien Ponthus and Ritvik Carvalho)
*****
OPENING SNAPSHOT: SEA OF RED ON TECH TREMORS, EARNINGS ANXIETY (0800 GMT)
The STOXX is set for its worst month since Aug 2015 as it sinks down 1.1 percent this morning in a broad selloff after results misses from Amazon (NASDAQ:AMZN) and Alphabet (NASDAQ:GOOGL) renewed anxiety about how fragile this tech-fuelled bull market might turn out to be.
Results-wise it's a triptych of terror for European investors: So far three main negative trends have emerged from company results: higher raw material and wage costs, the impact of tariffs, and a slowdown in China.
No surprises then that analysts are downgrading their MSCI Europe earning estimates at the fastest pace since Feb 2016, according to Refinitiv IBES data.
Car parts maker Valeo follows in the footsteps of auto peers with a warning on tougher European emissions rules and slowing China sales - driving its shares down 17 percent while peer Faurecia falls 6.9 percent. paper and packaging maker Viscofan has only just started trading and plunged as much as 22.5 percent after warning it would miss its full-year guidance. Reid)
*****
WHAT'S ON THE RADAR: STOCKS TO TUMBLE, VALEO SINKS ON PROFIT WARNING (0653 GMT)
It looked set to be a day of heavy losses for equity investors with European futures down sharply – 0.6 to 0.9 percent - after U.S. futures tumbled following results from Amazon and Alphabet– prompting renewed concerns about the dominance of tech in this market cycle.
Car parts maker Valeo could be the biggest faller of the day, indicated down 10 to 15 percent after its results missed estimates by 22 percent and it slashed guidance for next year by 11 percent. The warnings echoed Daimler's and others in the auto sector flagging disruption from tougher European emissions tests and slower sales in China, and the sector could be bruised as a result.
Stronger results from British Airways owner IAG (LON:ICAG) could help the travel & leisure sector which has been under pressure with airlines warning of fuel costs rising.
With some analysts citing a report Brexit talks are in deadlock, Britain's FTSE 100 will be a focus although sterling was unchanged on the day. Lender RBS (LON:RBS) said it had taken a 100 million pound impairment provision to account for greater economic uncertainty, the first concrete sign Brexit is clouding the outlook for banks.
Investors will also be digesting the impact on healthcare companies, including Roche and Novartis, of Trump's plan announced overnight to create a global pricing index for prescription drugs based on lower prices paid in other countries. the Europe-listed pharma names, Roche, Ipsen, Grifols and UCB have the biggest exposure to the U.S. Medicare Part B according to Goldman Sachs (NYSE:GS). One trading desk saw Roche falling 2 percent on the news.
(Helen Reid)
*****
FUTURES DOWN SHARPLY AS TECH SELLOFF, BREXIT DEADLOCK SAP RISK APPETITE (0617 GMT)
Futures have opened sharply lower, suggesting it's going to be a pretty heavy fall for European stocks after U.S. stock futures tumbled overnight on Amazon and Alphabet results.
A Bloomberg report that U.K. Prime Minister Theresa May's Cabinet is not close enough to agreeing a way forward for top level Brexit negotiations to resume is likely to add further uncertainty to UK markets. Reid)
*****
EARLY MORNING HEADLINES ROUND-UP: RYANAIR, VALEO, LAFARGEHOLCIM (0610 GMT)
A profit warning from French auto parts maker Valeo VLOF.PA - its second in three months - will underscore mounting concerns in the automotive sector about the impact of tougher European emissions tests and slowing sales growth in top market China. may get a lift after signing a preliminary contract deal with Belgian cabin crew and pilots as the budget airline aims to avert further strikes that have grounded planes and disrupted travel for thousands of customers. for action in the construction sector after LafargeHolcim, the world's largest cement maker, became the latest building materials company to warn of higher costs. The company reported consenus-busting Q3 earnings, but lowered its profit expectations due to rising fuel and raw materials costs. week German rival HeidelbergCement (DE:HEIG) trimmed its profit guidance, sending its shares down as much as 10 percent to a near four-year low.
In the chemicals sector, BASF posted slightly lower-than-expected quarterly profits and reiterated its full year guidance. from the onslaught of earnings, there is some IPO activity with shares in Danish cannabis oil firm StenoCare debuting, aiming to take advantage of a recent surge in investor interest in a substance that is still banned or restricted in many markets. bank Ibercaja has been in touch with advisers on a potential IPO, sources said, part of a legal requirement to protect the financial health of Spanish savings banks. Cars Q3 income falls due to launch costs, higher tariffs Caixabank Q3 net profit down 27.6 pct due to Repsol (MC:REP) sale manager Amundi reports higher Q3 profits beats expectations with 8 pct rise in Q3 core profit CEO Ermotti won't rule out M&A, says options are limited deals ready truck business Traton for stock market listing Ambev squeezed by Brazil competition, Argentina inflation receives UK approval for Brexit restructure open to offers for its $1 bln stake in Sunrise - CEO stake sale sparks merger talks among German public sector banks - sources eyes divestments of non-core businesses - handelsblatt newspaper Mason)
*****
EUROPEAN MARKETS HEADING SOUTH AGAIN (0525 GMT)
Any hope of a sustained recovery after yesterday's modest recovery across European markets will be dashed, with the market's facing further pressure at the open today, taking their lead from Asian and U.S. markets overnight.
FTSE 100 is expected to open 64 points lower at 6,940, DAX is expected to open 117 points down at 11,190 and CAC 40 is expected to open 62 points lower at 4,970, according to David Madden, market analyst at CMC Markets UK. (Josephine Mason) *****
<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ BLOG HEADSHOT
http://reut.rs/2y3Bc4f MSCI Europe earnings revised down sharply
https://tmsnrt.rs/2RipSq6 pot
https://tmsnrt.rs/2RgMM0K worst
https://tmsnrt.rs/2Rbl0Ti STOXX monthly
https://tmsnrt.rs/2Ri2SaG
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>